SCHEMBL8258476

SCHEMBL8258476

CC(C)(C)OC(=O)N1CCc2c(ccc(N3CCCC3=O)c2F)C1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.51
NR1H2 P55055 1/20 0.50
UCHL1 P09936 1/20 0.41
ADORA1 P30542 2/20 0.40
MAPK1 P28482 1/20 0.40
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
GPR119 Q8TDV5 2/20 0.38
DDB1 Q16531 2/20 0.38
CRBN Q96SW2 2/20 0.38
SCN9A Q15858 1/20 0.38
PARP1 P09874 1/20 0.38
TNKS2 Q9H2K2 1/20 0.38
PARP2 Q9UGN5 1/20 0.38
MKNK1 Q9BUB5 2/20 0.37
ACACB O00763 1/20 0.37
ABHD6 Q9BV23 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4183601 0.82 NR1H2 (0.49) ESR2NR1H2UCHL1ADORA1MAPK1
SCHEMBL31067476 0.81 NR1H2 (0.60) ESR2NR1H2UCHL1ADORA1MAPK1
SCHEMBL4165540 0.81 NR1H2 (0.60) ESR2NR1H2UCHL1ADORA1MAPK1
SCHEMBL8257610 0.81 NR1H2 (0.55) ESR2NR1H2ADORA1MAPK1MAPT
SCHEMBL4931191 0.80 NR1H2 (0.45) ESR2NR1H2UCHL1ADORA1MAPK1
SCHEMBL4929482 0.79 NR1H2 (0.55) ESR2NR1H2UCHL1ADORA1MAPK1
SCHEMBL8243756 0.79 NR1H2 (0.41) ESR2NR1H2UCHL1MAPK1NPC1
SCHEMBL29405503 0.78 ESR2 (0.55) ESR2NR1H2UCHL1ADORA1MAPK1
SCHEMBL19642882 0.78 ESR2 (0.55) ESR2NR1H2UCHL1ADORA1MAPK1
SCHEMBL20367262 0.78 ESR2 (0.54) ESR2NR1H2UCHL1ADORA1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006108709-A1 3-SULFONYLAMINO-PYRROLIDINE-2-ONE DERIVATIVES AS FACTOR XA INHIBITORS GLAXO GROUP LIMITED (GB) 2006-10-19 WO disclosed